PEGGY HUFFMAN: Open Payments
NPI 1437429362 · BECKLEY, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,051 in 105 payments from 16 companies in 2025. Trend: 2023 $1,261 · 2024 $1,215 · 2025 $2,051
Food & beverage: $2,016Education: $35
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $454 |
| GlaxoSmithKline, LLC. | 17 | $320 |
| GENZYME CORPORATION | 13 | $257 |
| Regeneron Healthcare Solutions, Inc. | 10 | $146 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $140 |
| Verona Pharma, Inc. | 9 | $140 |
| HARMONY BIOSCIENCES LLC | 4 | $116 |
| Actelion Pharmaceuticals US, Inc. | 4 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $83 |
| Amgen Inc. | 4 | $71 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, Ohtuvayre, FASENRA, BREZTRI, WAKIX, OFEV.
Industry payments across WV — which companies pay providers there.
